Target intelligence / Profile preview

Novel transcript, antisense to SET and PKN3

Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

The "novel transcript, antisense to SET and PKN3" (ENSG00000305868) is a long non-coding RNA (lncRNA) gene. It is categorized as an antisense transcript overlapping the SET and PKN3 loci, but it does not code for a protein and is not considered a classical therapeutic target such as a receptor or enzyme. There are currently no known drugs, mechanisms of action, disease associations, or biomarker utilities reported for this molecule. Its precise biological function remains uncharacterized, consistent with the general regulatory roles of lncRNAs and antisense RNAs[5].

Biological functions

Gene regulation (general function of lncRNAs and antisense RNAs)

Disease associations

Other (no direct evidence for involvement in major disease categories; function is mostly uncharacterized)

Beyond the preview

Go deeper on Novel transcript, antisense to SET and PKN3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to SET and PKN3.

Explore the full profile